Denali Therapeutics' Series A Round

Denali Therapeutics raised a round of funding on May 14, 2015.

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, AL…

Articles about Denali Therapeutics' Series A Round: